Open AccessIntensification of infliximab therapy in Crohn's disease: Efficacy and safety
Author(s) -
María Chaparro,
Pilar Martínez-Montiel,
Manuel Van Domselaar,
Fernando Bermejo,
J.L. Pérez-Calle,
B Casís,
Antonio López-San Román,
Alicia Algaba,
José Luís Mate,
Javier P. Gisbert
Publication year - 2011
Publication title -
journal of crohn s and colitis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.277
H-Index - 80
eISSN - 1876-4479
pISSN - 1873-9946
DOI - 10.1016/j.crohns.2011.07.005
Subject(s) - medicine , infliximab , crohn's disease , rescue therapy , disease , gastroenterology , intensive care medicine
The response of Crohn's disease (CD) to infliximab is initially good, although a loss of efficacy is observed over time. Dose escalation has been recommended in such cases.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom